|Mr. David Ian Johnson||Chief Exec. Officer, Pres, Director and Exec. Chairman of Aquamed Technologies Inc||606.4k||N/A||59|
|Mr. Brian M. Posner CPA, MBA.||Chief Financial Officer, Principal Accounting Officer, Treasurer and Sec.||349.2k||N/A||55|
|Mr. Bradford C. Barton||Chief Operating Officer||349.2k||N/A||57|
|Mr. Pellegrino Pionati||Chief Strategy & Marketing Officer||349.2k||N/A||59|
|Dr. Phillip D. Forman M.D., DPM||Exec. VP of Clinical Affairs||N/A||N/A||58|
Alliqua BioMedical, Inc., a regenerative technologies company, commercializes regenerative medical products that assist the body in the repair or replacement of soft tissue. It markets MIST Ultrasound Healing Therapy, a painless, noncontact, low-frequency ultrasound to promote healing; Biovance Amniotic Membrane Allograft and Interfyl Human Connective Tissue Matrix that are human biologic regenerative technologies; and TheraBond 3D Antimicrobial Barrier Systems that promotes an optimal wound healing by creating an antimicrobial barrier that helps protect against infection. The company also provides contract manufacturing services, including the development, manufacture, and market of high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. Alliqua BioMedical, Inc. has a license, marketing, development, and supply agreement with Anthrogenesis Corporation. The company is based in Yardley, Pennsylvania.
Alliqua BioMedical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.